| Serial Number | 79358521 |
| Word Mark | MONSPHERE |
| Filing Date | Thursday, February 10, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 28, 2023 |
| Registration Number | 7227089 |
| Registration Date | Tuesday, November 28, 2023 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, September 12, 2023 |
| Goods and Services | Pharmaceuticals preparations for the treatment and prevention of cancer; Medical preparations for the treatment of cancer and cancerous tumors; Veterinary preparations for cancer and cancerous tumors for animals; sanitary preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer for medical and veterinary purposes; Ginseng capsules for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for the diagnosis of pregnancy for medical and pharmaceutical purposes; chemical preparations for sanitary purposes for veterinary purposes; chemicopharmaceutical preparations for the treatment of cancer; Drug delivery agents in the form of beads, pills, liquid, capsules, dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of a coating for drug and pharmaceuticals preparations that facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment and prevention of circulatory diseases; pharmaceutical preparations for embolization for the treatment of blood vessels; pharmaceutical preparations for embolization of tumours and arteriovenous malformations (AVMs) for the treatment of circulatory conditions; pharmaceutical preparations for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medical purposes, vaccine adjuvants and adjuvants for use with vaccines; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations for the treatment of the circulatory system, vaccines and Antitoxic sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; diagnostic preparations for medical purposes; radioactive substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer; radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; pharmaceutical preparations in the form of particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive material for the treatment and prevention of cancer; pharmaceutical preparations in the form of microscopic particles containing radioactive pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations in the form of microcapsules containing pharmaceutical, veterinary or medical preparations for the treatment of cancer; pharmaceutical preparations in the form of microcapsules and microparticles adapted to selectively deliver radioactivity to a target for the treatment of cancer; pharmaceutical preparations in the form of microscopic particles and microcapsules for the treatment of cancer and other diseased cells; pharmaceutical preparations in the form of microscopic particles adapted to selectively deliver radioactive material to a target site such as a cell or organ for the treatment of cancer |
| Pseudo Mark | MONS HERE |
| Goods and Services | Surgical and medical apparatus and instruments for the treatment of cancer, radiological apparatus for medical purposes, radiology screens for medical purposes, namely, radiation shields for protection against X-rays for medical purposes; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body for the treatment of cancer; drug delivery embolisation apparatus, instruments and systems; medical apparatus and instruments for embolisation for the treatment of cancer; beads, impregnated with radioactive material or radioactive pharmaceutical preparations; microscopic glass beads being medical devices impregnated with radioactive material or radioactive pharmaceutical preparations and administered surgically for treatment of cancerous tumors; glass beads being medical devices containing radioactive material for the treatment of cancerous tumors; glass beads being medical devices containing radioactive pharmaceutical preparations for the treatment of cancerous tumors; implantable radiation therapy devices consisting of radioactive beads, namely, beads in the nature of microscopic radioactive beads for treatment of cancerous tumours; radioactive glass beads, namely, implantable radiation therapy devices consisting of radioactive beads for treatment of cancerous tumours; radioactive beads, namely, implantable radiation therapy devices consisting of radioactive glass beads administered for treatment of cancerous tumours; medical device, apparatus and instruments for treating cancer; Surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation, namely, embolic devices for use in treating cancer and tumors, embolic devices for treating arteriovenous malformations (AVMs) of the body, and embolic devices for use in treating tumors; drug delivery embolisation systems; drug delivery apparatus and instruments, namely, a drug delivery system comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation for the treatment of cancer; surgical and medical apparatus and instruments for use in the circulatory system for the treatment of cancer; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues for the treatment of cancer; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment for the treatment of cancer; surgical and medical devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles for treating cancer; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating for treating cancer; medical devices for ablating human and animal tissue using microwave energy for treating cancer; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts thereforfor all the aforesaid goods; medical apparatus and instruments, namely, beads impregnated with radioactive material for treatment of cancerous tumors, beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumours, beads containing radioactive material, glass beads containing radioactive pharmaceutical preparations, and microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumors, beads in the nature of microscopic glass beads impregnated with radioactive material or radioactive pharmaceutical preparations for treatment of cancerous tumours |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, December 27, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | TR |
| Party Name | ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | TR |
| Party Name | ECZACIBASI MONROL NÜKLEER ÜRÜNLER SANAYI VE TICARET ANONIM SIRKETI |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | TR |
| Event Date | Event Description |
| Tuesday, December 27, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 23, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, December 27, 2022 | ASSIGNED TO EXAMINER |
| Saturday, December 31, 2022 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 11, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, January 12, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, March 8, 2023 | REFUSAL PROCESSED BY MPU |
| Wednesday, March 8, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, March 29, 2023 | REFUSAL PROCESSED BY IB |
| Friday, July 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 28, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 4, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 23, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 30, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Friday, September 1, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, September 12, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, September 25, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 28, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 28, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, February 28, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, February 7, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, April 8, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, March 1, 2024 | GENERIC MADRID TRANSACTION CREATED |
| Saturday, March 2, 2024 | GENERIC MADRID TRANSACTION SENT TO IB |